Archived News for Health Sector Professionals
New research finds most national COVID-19 treatment guidelines recommend treatments that do not work.
Fines tightened for emergency attacks
Queensland is looking at tougher penalties for people who ram emergency services vehicles.
Gender split in doc's results
Medical patients might be less likely to die if their doctor is female.
Hydromorphone trial backed
Hydromorphone, a potent synthetic opioid, is a central element of Victoria’s new drug strategy.
Mental health leader resigns
The chair of Mental Health Australia has resigned citing profound disappointment with the Albanese government's ...
Senate seeks COVID probe
Political will could see Australia avoid learning lessons from the COVID-19 pandemic.
Detention report calls for change
The AHRC has called for an overhaul of Australia’s immigration detention system.
Cannabis gaps surveyed
Experts have described medicinal marijuana as the “Wild West” of Australian healthcare.
Lockdown effect seen in social work
New research looks at the stress, demand and pressure for social workers in Melbourne’s COVID-19 lockdown.
Mushroom effects checked
Experts have investigated the negatives of taking shroomies for the gloomys.
Pharmacists to drive vax boost
Pharmacists will soon be able to administer vaccines directly in aged care and disability homes.
State changes in bill fight
A federal-state tug-of-war over bulk billing is unlikely to leave any patients better off.
Brains reward altruism
Researchers say that the brain's reward system does not just function for selfish purposes.
Vaccine impact modelled
Research suggests COVID-19 vaccination significantly mitigated the death toll among older adults in NSW.
Radio sweep shows doses
A new study finds Melbourne's radio wave exposure has been unchanged over the past decade.
Data set on spotting disease
New diagnostics could bring new hope to millions suffering from autoimmune diseases.
Empathy tested by pain patients
Empathy in doctors appears to be linked to better chronic pain management.
MND pills tested
A South Australian patient is the first in the world to take part in a trial that could slow and even reverse the effects of Motor Neurone Disease (MND).